Transforming the treatment of gastrointestinal diseases. Mirai Medical is pioneering the use of endoscopic pulsed electric fields (PEF) to transform the treatment of gastrointestinal diseases. Our vision is clear: to deliver safe, fast, and effective ablation solutions that empower endoscopists and help patients feel like people again. With a CE-marked platform and more than 2,000 patients already treated in the EU and Australia, we are building on proven clinical experience to expand the reach of non-thermal electroporation therapies. Our scalable technology, strong intellectual property, and experienced team position us to redefine standards of care in interventional medicine. electroporation, endoscopy, cancer, …

95 similar entities Type: Startup Activities: manufacturing biotech deeptech healthtech Technologies: Synthetic Biology

Cancer monitoring made easy 🩸OncosemaTM️ is a purpose-driven company. Our mission is to dramatically improve the management of cancer patients by providing simple and non-invasive tools, to assist oncologists in making the best informed decisions for each patient. 🩸OncosemaTM️ is a deeptech start-up. We operate an exclusive technology targeting cancer-specific biomarkers, allowing the quantification and the isolation of Circulating Tumor Cells (CTC) from most types of cancer. 🩸OncosemaTM️ is focused on providing impactful tests for Oncology. ✔️Non-invasive ✔️Sensitive and specific ✔️Easy-to-use OncosemaTM️ is a registred trade mark of Oncocellex. Cancer, Diagnostic, Circulating Tumor Cells, Immunodiagnostic, Liquid Biopsy, Medical research, Patients …

66 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Unlocking the potential of solid samples in the field of biological diagnostic Diagante develops a solution for in vitro diagnostics. Its platform allows the analysis of solid clinical specimen on rapid and high throughput instruments in clinical pathology labs. It provides faster results, enhanced personalized medical care, and lower costs to the stakeholders.

144 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Cancer diagnostics in minutes, not days. Enabled by real-time molecular imaging technology. We are Refined, a medical technology company based in Münster, Germany, developing imaging technology for real-time cancer diagnostics. Today, critical diagnostic decisions often take hours or days because tissue samples are analyzed off-site in specialized labs. This delay can impact surgical workflows, treatment decisions, and patient outcomes. Refined is changing this by enabling molecular tissue analysis within minutes, directly at the point of care. Our high-precision laser microscopy empowers surgeons and pathologists to identify cancer cells during surgery, reducing repeat procedures, patient stress, and treatment costs. We have …

155 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I.

An innovative drug discovery technology Good morning and welcome, we are pleased to introduce you to our structure. AZELEAD has developed ZebraScreen and ZebraTox, an innovative methodology for rapid and accurate assessment of the efficacy and toxicity of a drug In the past few years, we have seen a lot of attrition in the development of new drugs, with a failure rate of nearly 84% attributed to the low benefit of efficacy / toxicity. Three therapeutic areas are mainly affected by this decrease:  oncology (failure rate of 29.5%),  neurology (failure rate of 14%),  and infectious diseases (failure …

288 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovative Solutions for Cancer Diagnostics OncoDiag est une société spécialisée dans le développement et la commercialisation de solutions innovantes pour le dépistage, le diagnostic et la surveillance des cancers, avec comme priorité le cancer de la vessie, le cancer colorectal et le cancer de la prostate. OncoDiag est une jeune entreprise innovante de biotechnologies principalement composée de médecins et de chercheurs. La société s'appuie sur un réseau d'experts de la communauté scientifique et clinique. Avec les cancers de la vessie, inscrits comme maladies professionnelles, OncoDiag s'adresse à un véritable problème de santé publique. Dans cette perspective OncoDiag a récemment développé, …

Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

EndoDrill® biopsy instruments for early and accurate cancer diagnostics. BiBBInstruments AB (BiBB) is a Swedish medtech company that develops and markets diagnostic instruments under the brand name EndoDrill® for early detection of cancer tumours. The company develops a family of patented biopsy instruments addressing major needs in diagnostics of the most common forms of cancer and operates in the global multi-billion endoscopy accessory market. BiBB’s vision is to offer innovative single-use biopsy instruments for earlier and more accurate diagnostics. The company was founded in 2013 by Dr Charles Walther, a cancer researcher at Lund University as well as senior physician …

Type: Startup Activities: deeptech biotech

Empowering precision medicine through advanced diagnosis CENTOGENE is a leading company in the field of genetic diagnostics and precision medicine, dedicated to transforming clinical, genetic, and biochemical data into medical solutions for patients. Based in Rostock, Germany, the company operates globally. Founded in 2006 with the mission of revolutionizing the diagnosis of rare diseases, CENTOGENE has since scaled its capabilities to diagnose more than 2,500 rare diseases in over 100 countries, building one of the largest genetic databases in the world (1,000,000 individuals) while developing cutting-edge technology for the interpretation of genetic data. With over 350 scientific publications, CENTOGENE is …

64 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Endometriosis, we talk about it. LOVE. acts Information, prevention, communication and support for endometriosis patients health, endometriosis, ETP, therapeutic patient education, and patient expert

62 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

An innovative biotech company set to revolutionize the rapid diagnostics market. ALTERDIAG was founded in 2024 with a mission to develop and market innovative lateral-flow immunochromatographic tests to provide healthcare professionals who interact with patients with efficient, easy-to-use, and economically accessible diagnostic tools. These tools are designed to enable epidemiological screening of infectious diseases, aiming to combat or prevent new epidemics or pandemics. AlterDiag aspires to be internationally recognized as an innovative company and a scientific leader in the field of rapid diagnostic tests. R&D is thus central to its activities, and the company is building partnerships with prominent players …

70 similar entities Type: Startup Activities: deeptech biotech

Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-learning solutions⚡ Incorporated in 2015 in Grenoble, Diabeloop is a Medtech company developing a comprehensive suite of AI-enabled tools to automate diabetes management. Our daily mission is to drastically reduce patients' mental burden while delivering proven clinical outcomes, including a significant increase in Time in Range (TIR) and a reduction in hypoglycemia. 💡 OUR TECHNOLOGY TODAY Our self-learning algorithm (DBLG1) is already used by many patients across Europe. Designed to be interoperable, our system adapts to individual physiologies by connecting with various insulin pumps. 🚀 A NEW …

Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology

Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection, leveraging the transformative potential of AI and our proprietary biomarker technology. At the heart of this innovation is our GlycoLocate platform, a multi-omics approach powered by lipids, metabolites and proteins. This platform is setting a new gold standard in the quest for life-saving early cancer diagnostics. We are now advancing AKRIVIS GDTM, a cutting-edge liquid biopsy test designed specifically for the early detection of ovarian cancer. Medical Devices, Diagnostics, Prognostics, Biotechnology, Sales, Commercialization, Regulatory, Licensing, Quality, FDA, IVD, CE IVDR, …

140 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Endocrinology Advisor is an online resource that provides health care professionals with comprehensive information on important principles of care in endocrinology as well as up-to-date clinical news on the diagnosis and treatment of endocrine conditions. Our mission is to offer the most recent clinical research news and evidence-based guidance that will aid health care professionals in the management of endocrine conditions.

53 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Innovative technology, safer outcomes. IDMED, a French company based in Marseille, develops and markets innovative medical devices in the fields of anesthesia and intensive care. Our products are used worldwide in operating theaters, intensive care units, neuro-ophthalmological consultations and research laboratories. Follow us on Facebook as well https://www.facebook.com/profile.php?id=100087269760737 Our products are commonly used in the areas of pupillometry, neuromuscular blockade monitoring and analgesia monitoring. IDMED develops products in collaboration with healthcare professionals. Innovation, reliability and relevance are the core qualities of our devices. We put our technical knowledge to the service of an improved everyday clinical practice. Healthcare, Medical device, …

367 similar entities Type: Startup Activities: deeptech manufacturing healthtech Technologies: Synthetic Biology

A French liquid biopsy technology dedicated to the isolation of circulating tumor cells (CTCs) The number of cancer cases continues to rise worldwide, and detection is occurring earlier and earlier. In this context, precision medicine is no longer optional — it has become essential. Tailoring treatments to the specific characteristics of each patient is key to improving survival rates and quality of life. ScreenCell® is fully committed to this approach by developing single-use devices designed to isolate circulating tumor cells (CTCs) from a simple blood sample. Our liquid biopsy technology offers a non-invasive and cost-effective alternative for accessing valuable insights …

218 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming diagnosis through gynecological fluids At MiMark, we believe that diagnosing a disease should never add more suffering to patients. That’s why we’ve developed a revolutionary diagnostic approach that uses gynecological fluids to diagnose gynecological diseases efficiently and accurately. Our mission is clear: to make gynecological diagnosis simpler, safer, and more human – for patients, clinicians, and healthcare systems alike. *Disease is complicated. Diagnosis shouldn't be.* For decades, women's health has been underestimated in research and diagnostics.Existing tests for gynecological diseases are often invasive, painful, costly, and sometimes inconclusive. At MiMark, we are changing that reality by developing protein-based diagnostics …

74 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Building a legacy in female health endogene.bio is building the biological data infrastructure for uterine health. 190 million women worldwide suffer from endometriosis, yet diagnosis still takes years and curative treatments remain unavailable. A fundamental challenge is the lack of high-quality human uterine biological data. By combining menstrual blood, advanced molecular profiling, and computational modeling, endogene.bio generates high-resolution biological data at scale, unlocking a previously inaccessible layer of human biology. Our work enables deeper understanding of disease mechanisms, patient stratification, biomarker discovery, and therapeutic development across uterine health. We collaborate with pharmaceutical companies, hospitals, clinics, and research organizations to accelerate …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unlocking the road to precision medicine in cancer care by tumor characterization via multiomics profiling and AI. Worldwide, there are more than 20 million new cases of cancer each year. First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patient’s lives and reduce the cost of expensive inefficient treatments. Our goal …

189 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning

Best-in-class monoclonal antibodies with Human Fc for IVD Based in Illkirch-Graffenstaden (France), Bcell Design redefines the standards of diagnostic excellence by providing cutting-edge solutions that address the industry’s most pressing challenges. We specialize in developing, producing, and commercializing monoclonal antibodies with Fc human domains: a superior alternative to disease plasma. Our antibodies are designed to deliver unmatched sensitivity and specificity, ensuring consistent and reliable performance for diagnostic test manufacturers worldwide. What sets us apart? → Unparalleled accuracy: Our monoclonal antibodies raise the bar with precision and performance you can trust. → Reliability you can count on: Designed to eliminate variability …

103 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

As one of the world's leading manufacturers of medical laboratory diagnostics, Euroimmun stands for innovation. More than 3,500 employees in 150 countries develop, produce and market test systems to aid in the diagnosis of diseases, as well as software and automation solutions to perform and evaluate these tests. Our products are used in laboratories, hospitals, health authorities and academic institutions in over 140 countries to support diagnostics and research of autoimmune and infectious diseases, as well as allergies and genetic diseases. Follow us on: YouTube: www.youtube.com/user/EUROIMMUN Blog: www.euroimmunblog.de Looking for amazing job opportunities? Purpose with Impact - People who care …

202 similar entities Type: SMB Activities: healthtech deeptech Technologies: SaaS

Building the foundational brick of clinical-grade evidence in women's health. Endometriosis is step 1. Matricis.ai brings the best science and cutting-edge machine learning algorithms to endometriosis research. We collaborate with radiologists to co-create medical-grade applications with the goal of improving diagnosis accuracy and democratizing the world's best specialists' expertise for all patients while saving time and reducing medical errancy.

57 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: A.I. A.I. - Machine Learning

Where AI meets brainwaves to redefine patient care. AI-assisted Electrophysiology Diagnostics BIOSerenity develops connected medical solutions to help diagnose and monitor patients with chronic diseases in neurology, sleep disorders and cardiology. We use physiological sensors, an IoT platform, apps and A.I. to detect digital biomarkers. We work with more than 200 hospitals in Europe and help diagnose over a hundred thousand patients per year. Our headquarter is in Paris, France. Medical Devices, e-Health, Neurology, Smart Clothing, Mobile Diagnostics, Sleep, Research, EEG, Polysomnography, Sleep diagnostic, and EEG Software

323 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: A.I.

Saving lives through innovative molecular diagnostic solutions. Mainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily identify the early onset of several leading deadly conditions including colorectal and pancreatic cancers. Visit our website www.mainzbiomed.com to learn more about our company and our mission to save lives through science. molecular genetic in-vitro diagnostics

129 similar entities Type: Startup Activities: deeptech biotech Technologies: Cybersecurity

Creative Technologies for Efficient Therapeutics, Precision medicine Inoviem Scientific is a private Bioanalytical company which delivers enabling information to secure drug discovery programs and to take informed decision by closing the gap between preclinical and clinical development. We reconcile translational pharmacology and human physiology by using fresh patient material from the target cohort, embracing the complexity of human diseases. Inoviem's enabling technologies are working in pathological conditions to get the treatment in development to the right patient. Our indication-agnostic access to patients combined with innovative label-free platforms deliver Target identification and validation, targets & Mode of Action deconvolution, patient stratification, …

198 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

313 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Innovation for Biotherapies BIOSYNEX was founded in 2005 and is one of the most significant European manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market. By staying close to our customers and business partners we are aware of the needs and expectations they may have of our products and services. Listening to their voice, together with the help of our Research and Development laboratories in France and our state of the art manufacturing facilities, allows us to identify new applications in rapid testing, develop and launch innovative products and provide high quality services. Our aim is to …

297 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Developing innovative solutions for therapeutic endoscopy Endo Tools Therapeutics (ETT) supports physicians with cutting-edge tools, securing patients with state-of-the-art care. ETT is a Belgian company dedicated to the development of innovative medical devices, providing new means of therapeutic interventions for endoscopists. Medical Device, Therapeutic Endoscopy, Research and Developpment, Project Engineering, Obesity, Clinical data, and Patient first

91 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We address the urgent, unmet needs in women’s pelvic health through thoughtful, design-driven innovation Sylvia Health addresses urgent, unmet needs in women’s pelvic health through thoughtful, design‐driven innovation. Pelvic organ prolapse affects more than 1 in 12 women, yet options between “watchful waiting” and surgery are limited and too often unsatisfying. We’re building practical, scalable solutions that fit women’s lives - starting with a clinically validated, user‐informed device for the (at least) 110 million women suffering from rectocele prolapse. Designed for today’s clinical realities, it’s simple to introduce, intuitive to self‐manage, and shaped to reduce clinical burden while improving daily …

102 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Enabling same-day cancer diagnostics from minimally invasive sample material X ZELL is a global pioneer in multiplexed immunostaining – a patented technology set to revolutionize cancer diagnostics by applying multiple diagnostic antibodies simultaneously to a single specimen. Our FDA and CE IVD registered next generation cytology platform was specifically designed for minimally invasive cytology samples and processes up to eight antibodies at once – maximizing diagnostic yield while cutting turnaround by over 90%. No complex preparation. No sample wastage. By combining multiplexing with cutting edge digital imaging, we help laboratories deliver faster, more patient friendly, and personalized care – ready …

114 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology

Molecular diagnostics for infectious diseases and antibiotic resistance management. Mobidiag is a biotechnology company specialized in development and commercialization of molecular diagnostics solutions used by clinical laboratories for detection of infectious diseases (gastrointestinal, respiratory and hospital-acquired infections) and antibiotic resistances (AMR). Mobidiag offers 2 solutions: - Amplidiag®, a multiplex qPCR-based product line comprising a large panel of diagnostic tests and the Amplidiag® Easy platform for automation of lab workflow. The Amplidiag® products are well suited for large laboratories with high-throughput screening (batch testing) requirements. - Novodiag® is a fully automated molecular diagnostics solution for both syndromic and targeted testing of …

64 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics

LYMPHOGENiX is a leading company for lymphatic vessel regeneration research based in the UK and Japan operating globally LYMPHOGENiX is a UK-based biotechnology company focused on developing first-in-class therapeutics for infertility, leveraging a novel and underexplored biological system: the lymphatic vasculature. Infertility remains a major and growing global health challenge, affecting millions of individuals and couples worldwide. Despite advances in assisted reproductive technologies, implantation failure and poor endometrial receptivity continue to limit success rates. LYMPHOGENiX was founded to address this unmet need by targeting a fundamental but overlooked component of reproductive biology. Our core scientific insight is that lymphatic vessels …

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases. Oxford BioDynamics (OBD) is a global biotech company advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases. OBD aims to help people face the most challenging health decisions with confidence and tackle the rising costs of healthcare with a portfolio of clinical tests and research tools based on its proprietary EpiSwitch® technology, uniquely capable of reproducibly translating 3D genome regulation for clinical application. The company’s flagship product, EpiSwitch CiRT (Checkpoint inhibitor Response Test), is a first-of-its-kind smart blood test for cancer patients that …

80 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Data Analytics

ELISA, PCR and rapid tests for the diagnosis of human and zoonotic infectious diseases. Since 2004, Innovative Diagnostics (ID) develops, produces and sells ELISA, PCR and rapid tests to diagnose infectious zoonotic and veterinary diseases. Over 130 employees work in our 4000 m2 headquarters at the heart of the “MED Valley” of Montpellier, France. ID has shown continuous growth over the years and offers a wide range of veterinary tests sold in over 100 countries under the brand name IDvet. ID is an actor of the One Health approach, which recognizes that human and animal health are interdependent. We contribute …

69 similar entities Type: SMB Activities: deeptech manufacturing

The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. …

280 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Aminogram designs, produces and markets innovative medical devices in La Ciotat in France. Created in 2003, Aminogram designs, produces and markets innovative medical devices for analyzing body composition. Our solutions are recognized for their reliability and practicality and are used in both research and clinical nutrition. At the forefront of innovation, the Biody XpertzM 3 uses bioelectrical impedance spectroscopy (BIS) technologies for non-invasive clinical assessment and precise monitoring of body composition. This patented 2-in-1 device allows measurements with or without cables, offering optimal flexibility. Made in France and CE Medical Class IIa certified under MDR regulations, the Biody XpertzM 3 …

96 similar entities Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD …

203 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Quantifying cervical biomechanics for OBGYN Innitius is a medtech company focused on bringing a new diagnostic dimension to women’s health through cervical biomechanics. Our platform combines a CE-marked medical device with AI-based decision support to provide objective and quantitative assessment of cervical tissue, complementing existing ultrasound-based approaches. Designed to complement ultrasound, the technology captures biomechanical changes that are not visible through imaging alone. The company works with a growing network of leading hospitals across Europe and is expanding its clinical programs through multicenter studies across different applications in OBGYN. Innitius is advancing clinical validation while progressively scaling its presence in …

136 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I.

Enhancing digestive health GoodGut is a biotechnology company focused on researching and developing analysis systems and therapeutic products to improve the diagnosis and treatment of digestive diseases based on intestinal microbiota. We aim to provide technological tools that will help to obtain a faster, more reliable and lower cost medical diagnosis than existing methods, alongside therapies to improve the quality of life of patients with compromised digestive health. The company was created in 2014 as a spin-off of the University of Girona (UdG) and the Institute of Biomedical Research of Girona Dr. Josep Trueta (IdIBGi). Our facilities can be found …

164 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Endomag is a medical technology company devoted to improving the global standard of cancer care. Our Sentimag® system, Magseed® marker and Magtrace® lymphatic tracer are used by thousands of the world’s leading physicians and cancer centres. Our goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. We’ve helped tens of thousands of women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), we continue to develop our unique …

191 similar entities Type: Startup Activities: healthtech deeptech Technologies: SaaS

Transform gynecological medical ultrasound in objective, easy-to-read information with custom Artificial Intelligence. Healthcare where and when it is needed. SynDiag develops solutions for gynecological ultrasound scan interpretation and helps medical doctors to focus where it matters to take accurate clinical decisions, fast and in any condition. SynDiag solutions are based on custom Artificial Intelligence algorithms, today mainly focused on ovarian cancer diagnosis. They can be adopted with any ultrasound scan machine, both in clinics and with portable devices. artificial intelligence, gynecology, cancer, ovarian cancer, computer vision, uterine cancer, endometriosis, academia, research, digital medicine, and telemedicine

73 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

Learned society - Information, training, research, ... - Organizer of the Video-Digest Intensive Course congress The SFED is responsible for issuing recommendations for the good practice of endoscopy, organizing regional training meetings, participating in the teaching and training of future endoscopists, reflecting on the future development of imaging techniques applied to endoscopy and on the new therapeutic possibilities of endoscopy. It contributes to the development of endoscopy equipment and conditions. It provides evidence and scientific support for the practice of endoscopy... Endoscopy, Medicine, Medical Imaging, Training, and Congress

36 similar entities Type: SMB Activities: edtech Technologies: Synthetic Biology

A tissue-level multidisciplinary approach to curing Endometriosis. Our mission is to cure endometriosis. We are a team of interdisciplinary scientists creating a new model in women's health research centred around an in depth understanding of tissue-level disease processes. We are committed to improving the quality of life of women by providing a new model for therapeutic discovery. We sit at the interface between tissue biology, computation and laboratory disease modelling.

62 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

A patient focused, discovery driven life science company. Our mission is to bring clarity to complex autoimmune diseases by empowering physicians, and our partners across healthcare and biopharma, with advanced testing solutions that enable earlier, more accurate diagnoses and better patient outcomes. Through our AVISE® testing portfolio, we deliver the industry’s most comprehensive rheumatology diagnostic platform — integrating serology, cell-based assays, proprietary biomarkers, and a validated algorithm. Exagen is the only company to offer CB-CAPS, T Cell markers, anti-PAD4 and anti-RA33 testing commercially, and the pioneer in clinically validating these biomarkers for SLE and rheumatoid arthritis (RA), respectively. We also …

96 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

We Bring Innovation to APS Care Endotelix is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Endotelix is dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome, including diagnostic tests and therapies. diagnostics, Biotech, APS, and LFA

51 similar entities Type: Startup Activities: healthtech deeptech

Innovating at the intersection of neuroscience and ophthalmology machineMD is a medical device company, headquartered in Switzerland, with a subsidiary in Boston, USA, that is innovating at the intersection of neuroscience and ophthalmology. The company’s mission is to radically improve the measurement of brain function, with a vision for a world where people receive an accurate, fast, and early diagnosis of brain disorders. Together with a global network of clinical and research partners, our goal is to bring the diagnostic quality of highly trained tertiary care specialists where it is needed most, in primary and secondary care. 🏆 VSP Innovation …

83 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

We are a worldwide leading manufacturer in cell counting and analysis. Born in Scandinavia, operating globally. ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments. We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences. Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship. Find us on Glassdoor: https://bit.ly/3pjjzTA Manufacturing Cell Counters, Manufacturing Cell Analyzers, …

434 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology